Telescope Provides a Corporate Update
March 1, 2022 — Over the past year, we have established a growing intellectual property portfolio on pharmaceutical manufacturing,
increased in-house research capacity and proprietary research platforms, and brought in award winning scientific leadership.
Telescope Files Patent Cooperation Treaty Application on Scalable Psilocybin and Tryptamine Synthesis
Jan 17, 2022 — This patent represents a key milestone in addressing the impending manufacturing bottleneck for pharmaceutical-grade psilocybin and psychedelic tryptamines.
Telescope Announces Acquisition of Rights to Synthetic Psilocybin Research
Nov 29, 2021 — We are excited to have come to this agreement with UBC allowing us freedom to own and continue developing our intellectual property.
